{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:14:05Z","timestamp":1790957645428,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-024-04634-8","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:23:29Z","timestamp":1727882609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2836-715X","authenticated-orcid":false,"given":"Saeideh","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-4099","authenticated-orcid":false,"given":"Majid","family":"Sadeghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-0774","authenticated-orcid":false,"given":"Mohammad Reza","family":"Aghasadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0097-9779","authenticated-orcid":false,"given":"Mehdi Shafiee","family":"Ardestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh Adib","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-553X","authenticated-orcid":false,"given":"Roohollah","family":"Vahabpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"4634_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.med.59.061506.185523","volume":"59","author":"JR Heath","year":"2008","unstructured":"Heath JR, Davis ME. Nanotechnology and cancer. Annu Rev Med. 2008;59:251. https:\/\/doi.org\/10.1146\/annurev.med.59.061506.185523.","journal-title":"Annu Rev Med"},{"issue":"2","key":"4634_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2217\/nnm.10.1","volume":"5","author":"T Mamo","year":"2010","unstructured":"Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Farokhzad. O. C. Emerging nanotechnology approaches for HIV\/AIDS treatment and prevention. Nanomedicine. 2010;5(2):269\u201385. https:\/\/doi.org\/10.2217\/nnm.10.1.","journal-title":"Nanomedicine"},{"issue":"1","key":"4634_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-020-01908-5","volume":"22","author":"D Pradhan","year":"2021","unstructured":"Pradhan D, Biswasroy P, Goyal A, Ghosh G, Rath G. Recent advancement in nanotechnology-based drug delivery system against viral infections. AAPS PharmSciTech. 2021;22(1):1\u201319. https:\/\/doi.org\/10.1208\/s12249-020-01908-5.","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"4634_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1517\/17425247.5.9.927","volume":"5","author":"OC Farokhzad","year":"2008","unstructured":"Farokhzad OC. Nanotechnology for drug delivery: the perfect partnership. Expert Opin Drug Deliv. 2008;5(9):927\u20139. https:\/\/doi.org\/10.1517\/17425247.5.9.927.","journal-title":"Expert Opin Drug Deliv"},{"issue":"9","key":"4634_CR5","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1021\/nl102184c","volume":"10","author":"J Shi","year":"2010","unstructured":"Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 2010;10(9):3223\u201330. https:\/\/doi.org\/10.1021\/nl102184c.","journal-title":"Nano Lett"},{"key":"4634_CR6","doi-asserted-by":"publisher","unstructured":"Sepulveda-Crespo D, Gomez R, De La Mata FJ, Jimenez JL, Mu\u00f1oz-Fern\u00e1ndez M. \u00c1. Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment\/therapy. Nanomedicine: Nanotechnology, Biology and Medicine. 2015;11(6):1481\u20131498. https:\/\/doi.org\/10.1016\/j.nano.2015.03.008","DOI":"10.1016\/j.nano.2015.03.008"},{"key":"4634_CR7","doi-asserted-by":"crossref","unstructured":"Nachega, J.B., Musoke P., Kilmarx, P.H., Gandhi, M., Grinsztejn, B., Pozniak, A., Rawat, A., Wilson, L., Mills, E.J., Altice, F.L., Mellors, J.W. Global HIV control: is the glass half empty or half full? The Lancet HIV. 2023; 10(9): 617\u2013622.","DOI":"10.1016\/S2352-3018(23)00150-9"},{"key":"4634_CR8","doi-asserted-by":"publisher","unstructured":"Cooper, D. A., Heera, J., Ive, P., Botes, M., Dejesus, E., Burnside, R., \u2026 van Der Ryst, E. Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings. AIDS (London, England). 2014;28(5):717. https:\/\/doi.org\/10.1097\/QAD.0000000000000131","DOI":"10.1097\/QAD.0000000000000131"},{"key":"4634_CR9","doi-asserted-by":"publisher","unstructured":"Vacas-Cordoba E, Galan M, de la Mata FJ, Gomez R, Pion M, Mu\u00f1oz-Fern\u00e1ndez M. \u00c1. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides. International Journal of Nanomedicine. 2014;9:3591. https:\/\/doi.org\/10.2147\/IJN.S62673","DOI":"10.2147\/IJN.S62673"},{"issue":"5919","key":"4634_CR10","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.1165706","volume":"323","author":"DD Richman","year":"2009","unstructured":"Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323(5919):1304\u20137. https:\/\/doi.org\/10.1126\/science.1165706.","journal-title":"Science"},{"key":"4634_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.carbpol.2017.10.102","volume":"182","author":"P Yadav","year":"2018","unstructured":"Yadav P, Bandyopadhyay A, Chakraborty A, Sarkar K. Enhancement of anticancer activity and drug delivery of chitosan-curcumin nanoparticle via molecular docking and simulation analysis. Carbohydr Polym. 2018;182:188\u201398. https:\/\/doi.org\/10.1016\/j.carbpol.2017.10.102.","journal-title":"Carbohydr Polym"},{"issue":"6 Suppl 3","key":"4634_CR12","first-page":"21","volume":"69","author":"SL Krosch","year":"2010","unstructured":"Krosch SL. Perceptions and use of complementary and alternative medicine in american Samoa: a survey of health care providers. Hawaii Med J. 2010;69(6 Suppl 3):21.","journal-title":"Hawaii Med J"},{"issue":"1","key":"4634_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6882-14-344","volume":"14","author":"NH Yim","year":"2014","unstructured":"Yim NH, Kim A, Liang C, Cho WK, Ma JY. Guibitang, a traditional herbal medicine, induces apoptotic death in A431 cells by regulating the activities of mitogen-activated protein kinases. BMC Complement Altern Med. 2014;14(1):1\u201312. https:\/\/doi.org\/10.1186\/1472-6882-14-344.","journal-title":"BMC Complement Altern Med"},{"issue":"1\u20132","key":"4634_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijpharm.2016.05.003","volume":"507","author":"QT Phan","year":"2016","unstructured":"Phan QT, Le MH, Le TTH, Tran THH, Xuan PN, Ha PT. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA: PEG ratios. Int J Pharm. 2016;507(1\u20132):32\u201340. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.05.003.","journal-title":"Int J Pharm"},{"issue":"5","key":"4634_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.fct.2011.02.004","volume":"49","author":"MA El-Moselhy","year":"2011","unstructured":"El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SF, Ahmed AF. The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-\u03b1 and free fatty acids. Food Chem Toxicol. 2011;49(5):1129\u201340. https:\/\/doi.org\/10.1016\/j.fct.2011.02.004.","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"4634_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.intimp.2010.08.014","volume":"11","author":"RM Srivastava","year":"2011","unstructured":"Srivastava RM, Singh S, Dubey SK, Misra K, Khar A. Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol. 2011;11(3):331\u201341. https:\/\/doi.org\/10.1016\/j.intimp.2010.08.014.","journal-title":"Int Immunopharmacol"},{"key":"4634_CR17","doi-asserted-by":"publisher","unstructured":"Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Mol Targets Therapeutic uses Curcumin Health Disease. 2007;1\u201375. https:\/\/doi.org\/10.1007\/978-0-387-46401-5_1.","DOI":"10.1007\/978-0-387-46401-5_1"},{"issue":"6","key":"4634_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u201318. https:\/\/doi.org\/10.1021\/mp700113r.","journal-title":"Mol Pharm"},{"issue":"1","key":"4634_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2891-13-11","volume":"13","author":"R J\u00e4ger","year":"2014","unstructured":"J\u00e4ger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparative absorption of curcumin formulations. Nutr J. 2014;13(1):1\u20138. https:\/\/doi.org\/10.1186\/1475-2891-13-11.","journal-title":"Nutr J"},{"issue":"5","key":"4634_CR20","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/jf104402t","volume":"59","author":"RK Basniwal","year":"2011","unstructured":"Basniwal RK, Buttar HS, Jain VK, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem. 2011;59(5):2056\u201361. https:\/\/doi.org\/10.1021\/jf104402t.","journal-title":"J Agric Food Chem"},{"issue":"19","key":"4634_CR21","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1158\/1078-0432.CCR-07-5177","volume":"14","author":"D Wang","year":"2008","unstructured":"Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Wang MB. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor \u03baB by an AKT-independent pathway. Clin Cancer Res. 2008;14(19):6228\u201336. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5177.","journal-title":"Clin Cancer Res"},{"key":"4634_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/ijn.s5581","volume":"4","author":"V Gupta","year":"2009","unstructured":"Gupta V, Aseh A, R\u00edos CN, Aggarwal BB, Mathur AB. Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int J Nanomed. 2009;4:115. https:\/\/doi.org\/10.2147\/ijn.s5581.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4634_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.nano.2009.05.009","volume":"6","author":"RK Das","year":"2010","unstructured":"Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomed Nanotechnol Biol Med. 2010;6(1):153\u201360. https:\/\/doi.org\/10.1016\/j.nano.2009.05.009.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1\u20132","key":"4634_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.09.025","volume":"330","author":"K Maiti","year":"2007","unstructured":"Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin\u2013phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007;330(1\u20132):155\u201363. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.09.025.","journal-title":"Int J Pharm"},{"key":"4634_CR25","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.2147\/IJN.S25534","volume":"6","author":"MM Yallapu","year":"2011","unstructured":"Yallapu MM, Ebeling MC, Chauhan N, Jaggi M, Chauhan SC. Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomed. 2011;6:2779. https:\/\/doi.org\/10.2147\/IJN.S25534.","journal-title":"Int J Nanomed"},{"key":"4634_CR26","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.jddst.2022.103382","volume":"74","author":"EA Dezfouli","year":"2022","unstructured":"Dezfouli EA, Kiaie SH, Danafar H, Nomani A, Sadeghizadeh M. BTN-PEG-PCL nanoparticles for targeted delivery of curcumin: in vitro and in Ovo assessment. J Drug Deliv Sci Technol. 2022;74:103382. https:\/\/doi.org\/10.1016\/j.jddst.2022.103382.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4634_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ejpb.2019.07.024","volume":"142","author":"AS Reddy","year":"2019","unstructured":"Reddy AS, Lakshmi BA, Kim S, Kim J. Synthesis and characterization of acetyl curcumin-loaded core\/shell liposome nanoparticles via an electrospray process for drug delivery, and theranostic applications. Eur J Pharm Biopharm. 2019;142:518\u201330. https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.024.","journal-title":"Eur J Pharm Biopharm"},{"key":"4634_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exer.2018.11.017","volume":"179","author":"YH Cheng","year":"2019","unstructured":"Cheng YH, Ko YC, Chang YF, Huang SH, Liu CJ. L. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment. Exp Eye Res. 2019;179:179\u201387. https:\/\/doi.org\/10.1016\/j.exer.2018.11.017.","journal-title":"Exp Eye Res"},{"issue":"1","key":"4634_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1039\/C9FO00901A","volume":"11","author":"M Gao","year":"2020","unstructured":"Gao M, Long X, Du J, Teng M, Zhang W, Wang Y, Li J. Enhanced curcumin solubility and antibacterial activity by encapsulation in PLGA oily core nanocapsules. Food Funct. 2020;11(1):448\u201355. https:\/\/doi.org\/10.1039\/C9FO00901A.","journal-title":"Food Funct"},{"key":"4634_CR30","doi-asserted-by":"publisher","first-page":"109810","DOI":"10.1016\/j.msec.2019.109810","volume":"104","author":"M Ayubi","year":"2019","unstructured":"Ayubi M, Karimi M, Abdpour S, Rostamizadeh K, Parsa M, Zamani M, Saedi A. Magnetic nanoparticles decorated with PEGylated curcumin as dual targeted drug delivery: synthesis, toxicity and biocompatibility study. Mater Sci Engineering: C. 2019;104:109810. https:\/\/doi.org\/10.1016\/j.msec.2019.109810.","journal-title":"Mater Sci Engineering: C"},{"key":"4634_CR31","doi-asserted-by":"publisher","unstructured":"Lian, T., Peng, M., Vermorken, A. J., Jin, Y., Luo, Z., Van de Ven, W. J., \u2026 Cui,Y. Synthesis and characterization of curcumin-functionalized HP-\u03b2-CD-modified GoldMag nanoparticles as drug delivery agents. Journal of nanoscience and nanotechnology. 2016;16(6):6258\u20136264. https:\/\/doi.org\/10.1166\/jnn.2016.11370.","DOI":"10.1166\/jnn.2016.11370"},{"issue":"1","key":"4634_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-3155-5-3","volume":"5","author":"S Bisht","year":"2007","unstructured":"Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy. J Nanobiotechnol. 2007;5(1):1\u201318. https:\/\/doi.org\/10.1186\/1477-3155-5-3.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"4634_CR33","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.3390\/molecules17055972","volume":"17","author":"Y Chen","year":"2012","unstructured":"Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 2012;17(5):5972\u201387. https:\/\/doi.org\/10.3390\/molecules17055972.","journal-title":"Molecules"},{"issue":"1\u20132","key":"4634_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijpharm.2010.07.021","volume":"398","author":"RS Mulik","year":"2010","unstructured":"Mulik RS, M\u00f6nkk\u00f6nen J, Juvonen RO, Mahadik KR, Paradkar AR. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm. 2010;398(1\u20132):190\u2013203. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.07.021.","journal-title":"Int J Pharm"},{"issue":"05","key":"4634_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1055\/s-0042-103161","volume":"83","author":"MC Falconieri","year":"2017","unstructured":"Falconieri MC, Adamo M, Monasterolo C, Bergonzi MC, Coronnello M, Bilia AR. New dendrimer-based nanoparticles enhance curcumin solubility. Planta Med. 2017;83(05):420\u20135. https:\/\/doi.org\/10.1055\/s-0042-103161.","journal-title":"Planta Med"},{"issue":"1","key":"4634_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.intimp.2011.11.015","volume":"12","author":"E Babaei","year":"2012","unstructured":"Babaei E, Sadeghizadeh M, Hassan ZM, Feizi MAH, Najafi F, Hashemi SM. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. Int Immunopharmacol. 2012;12(1):226\u201334. https:\/\/doi.org\/10.1016\/j.intimp.2011.11.015.","journal-title":"Int Immunopharmacol"},{"key":"4634_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/IJN.S48136","volume":"9","author":"MT Mirgani","year":"2014","unstructured":"Mirgani MT, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, Babaei E. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. Int J Nanomed. 2014;9:403. https:\/\/doi.org\/10.2147\/IJN.S48136.","journal-title":"Int J Nanomed"},{"issue":"1\u20132","key":"4634_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.04.027","volume":"394","author":"K Jain","year":"2010","unstructured":"Jain K, Kesharwani P, Gupta U, Jain NK. Dendrimer toxicity: Let\u2019s meet the challenge. Int J Pharm. 2010;394(1\u20132):122\u201342. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.04.027.","journal-title":"Int J Pharm"},{"issue":"15","key":"4634_CR39","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.addr.2005.09.012","volume":"57","author":"A D\u2019Emanuele","year":"2005","unstructured":"D\u2019Emanuele A, Attwood D. Dendrimer\u2013drug interactions. Adv Drug Deliv Rev. 2005;57(15):2147\u201362. https:\/\/doi.org\/10.1016\/j.addr.2005.09.012.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"4634_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijpharm.2007.02.037","volume":"339","author":"E Markatou","year":"2007","unstructured":"Markatou E, Gionis V, Chryssikos GD, Hatziantoniou S, Georgopoulos A, Demetzos C. Molecular interactions between dimethoxycurcumin and pamam dendrimer carriers. Int J Pharm. 2007;339(1\u20132):231\u20136. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.02.037.","journal-title":"Int J Pharm"},{"issue":"9","key":"4634_CR41","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0014-3057(03)00100-9","volume":"39","author":"F Aulenta","year":"2003","unstructured":"Aulenta F, Hayes W, Rannard S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur Polymer J. 2003;39(9):1741\u201371. https:\/\/doi.org\/10.1016\/S0014-3057(03)00100-9.","journal-title":"Eur Polymer J"},{"issue":"22","key":"4634_CR42","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1016\/j.biomaterials.2007.04.004","volume":"28","author":"P Agrawal","year":"2007","unstructured":"Agrawal P, Gupta U, Jain NK. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials. 2007;28(22):3349\u201359. https:\/\/doi.org\/10.1016\/j.biomaterials.2007.04.004.","journal-title":"Biomaterials"},{"issue":"7","key":"4634_CR43","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/S0014-3057(02)00385-3","volume":"39","author":"H Namazi","year":"2003","unstructured":"Namazi H, Adeli M. Novel linear\u2013globular thermoreversible hydrogel ABA type copolymers from dendritic citric acid as the A blocks and poly (ethyleneglycol) as the B block. Eur Polymer J. 2003;39(7):1491\u2013500. https:\/\/doi.org\/10.1016\/S0014-3057(02)00385-3.","journal-title":"Eur Polymer J"},{"issue":"10","key":"4634_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.biomaterials.2004.04.014","volume":"26","author":"H Namazi","year":"2005","unstructured":"Namazi H, Adeli M. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials. 2005;26(10):1175\u201383. https:\/\/doi.org\/10.1016\/j.biomaterials.2004.04.014.","journal-title":"Biomaterials"},{"key":"4634_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/ijn.s8595","volume":"5","author":"I Haririan","year":"2010","unstructured":"Haririan I, Alavidjeh MS, Khorramizadeh MR, Ardestani MS, Ghane ZZ, Namazi H. Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines. Int J Nanomed. 2010;5:63. https:\/\/doi.org\/10.2147\/ijn.s8595.","journal-title":"Int J Nanomed"},{"issue":"4","key":"4634_CR46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s10856-009-3978-8","volume":"21","author":"MS Alavidjeh","year":"2010","unstructured":"Alavidjeh MS, Haririan I, Khorramizadeh MR, Ghane ZZ, Ardestani MS, Namazi H. Anionic linear-globular dendrimers: biocompatible hybrid materials with potential uses in nanomedicine. J Mater Science: Mater Med. 2010;21(4):1121\u201333. https:\/\/doi.org\/10.1007\/s10856-009-3978-8.","journal-title":"J Mater Science: Mater Med"},{"key":"4634_CR47","doi-asserted-by":"publisher","unstructured":"Zabihollahi R, Sadat S, Vahabpour R, Aghasadegh M, Memarnejadian A, Ghazanfari T, Azadmanesh K. Development of single-cycle replicable human immunodeficiency virus 1 mutants. Acta Virol. 2011;55(1). https:\/\/doi.org\/10.4149\/av_2011_01_15.","DOI":"10.4149\/av_2011_01_15"},{"issue":"5","key":"4634_CR48","first-page":"227","volume":"12","author":"A Rezaei","year":"2007","unstructured":"Rezaei A, Zabihollahi R, SALEHI M, Moghim SH, Yazdanpanahi TAMIZIFH, N., Amini G. Designing a non-virulent HIV-1 strain: potential implications for vaccine and experimental research. J Res Med Sci. 2007;12(5):227\u201334.","journal-title":"J Res Med Sci"},{"issue":"1","key":"4634_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1039\/B309043B","volume":"33","author":"U Boas","year":"2004","unstructured":"Boas U, Heegaard PM. Dendrimers in drug research. Chem Soc Rev. 2004;33(1):43\u201363. https:\/\/doi.org\/10.1039\/B309043B.","journal-title":"Chem Soc Rev"},{"issue":"25","key":"4634_CR50","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1016\/j.biomaterials.2010.04.062","volume":"31","author":"C Mohanty","year":"2010","unstructured":"Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597\u2013611.","journal-title":"Biomaterials"},{"key":"4634_CR51","doi-asserted-by":"crossref","unstructured":"Erfani-Moghadam V, Nomani A, Zamani M, Yazdani Y, Najafi F, Sadeghizadeh M. A novel diblock of copolymer of (monomethoxy poly [ethylene glycol]-oleate) with a small hydrophobic fraction to make stable micelles\/polymersomes for curcumin delivery to cancer cells. Int J Nanomed. 2014; 5541\u201354.","DOI":"10.2147\/IJN.S63762"},{"issue":"1\u20132","key":"4634_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijpharm.2016.05.003","volume":"507","author":"QT Phan","year":"2016","unstructured":"Phan QT, Le MH, Le TTH, Tran THH, Xuan PN, Ha PT. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA: PEG ratios. Int J Pharm. 2016;507(1\u20132):32\u201340.","journal-title":"Int J Pharm"},{"key":"4634_CR53","doi-asserted-by":"crossref","unstructured":"Waghela BN, Sharma A, Dhumale S, Pandey SM, Pathak C. Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells. PLoS ONE. 2015; 10(2), e0117526.","DOI":"10.1371\/journal.pone.0117526"},{"issue":"12","key":"4634_CR54","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1021\/cn200088r","volume":"2","author":"S Dolai","year":"2011","unstructured":"Dolai S, Shi W, Corbo C, Sun C, Averick S, Obeysekera D, Raja K. Clickedsugar\u2013curcumin conjugate: modulator of amyloid-\u03b2 and tau peptide aggregation at ultralow concentrations. ACS Chem Neurosci. 2011;2(12):694\u20139. https:\/\/doi.org\/10.1021\/cn200088r.","journal-title":"ACS Chem Neurosci"},{"issue":"24","key":"4634_CR55","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1021\/jm700988f","volume":"50","author":"A Safavy","year":"2007","unstructured":"Safavy A, Raisch KP, Mantena S, Sanford LL, Sham SW, Krishna NR, Bonner JA. Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem. 2007;50(24):6284\u20138. https:\/\/doi.org\/10.1021\/jm700988f.","journal-title":"J Med Chem"},{"key":"4634_CR56","doi-asserted-by":"publisher","unstructured":"Tang, H., Murphy, C. J., Zhang, B., Shen, Y., Sui, M., Van Kirk, E. A., \u2026 Murdoch,W. J. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects. Nanomedicine. 2010;5(6):855\u2013865. https:\/\/doi.org\/10.2217\/nnm.10.67.","DOI":"10.2217\/nnm.10.67"},{"issue":"34","key":"4634_CR57","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1039\/c3tb20724b","volume":"1","author":"J Zhu","year":"2013","unstructured":"Zhu J, Shi X. Dendrimer-based nanodevices for targeted drug delivery applications. J Mater Chem B. 2013;1(34):4199\u2013211.","journal-title":"J Mater Chem B"},{"issue":"15","key":"4634_CR58","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.addr.2005.09.014","volume":"57","author":"AK Patri","year":"2005","unstructured":"Patri AK, Kukowska-Latallo JF, Baker JR Jr. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev. 2005;57(15):2203\u201314.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4634_CR59","first-page":"63","volume":"1","author":"H Namazi","year":"2011","unstructured":"Namazi H, Motamedi S, Namvari M. Synthesis of new functionalized citric acid-based dendrimers as nanocarrier agents for drug delivery. BioImpacts: BI. 2011;1(1):63.","journal-title":"BioImpacts: BI"},{"issue":"26","key":"4634_CR60","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.1021\/ol702370m","volume":"9","author":"W Shi","year":"2007","unstructured":"Shi W, Dolai S, Rizk S, Hussain A, Tariq H, Averick S, Raja K. Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications. Org Lett. 2007;9(26):5461\u20134. https:\/\/doi.org\/10.1021\/ol702370m.","journal-title":"Org Lett"},{"issue":"10","key":"4634_CR61","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2174\/18715206113139990139","volume":"13","author":"S Debnath","year":"2013","unstructured":"Debnath S, Saloum D, Dolai S, Sun C, Averick S, Raja K, Fata E. Dendrimer-curcumin conjugate: a water soluble and effective cytotoxic agent against breast cancer cell lines. Anti-Cancer Agents Med Chem (Formerly Curr Med Chemistry-Anti-Cancer Agents). 2013;13(10):1531\u20139. https:\/\/doi.org\/10.2174\/18715206113139990139.","journal-title":"Anti-Cancer Agents Med Chem (Formerly Curr Med Chemistry-Anti-Cancer Agents)"},{"key":"4634_CR62","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.2147\/IJN.S33015","volume":"7","author":"S Alam","year":"2012","unstructured":"Alam S, Panda JJ, Chauhan VS. Novel dipeptide nanoparticles for effective curcumin delivery. Int J Nanomed. 2012;7:4207. https:\/\/doi.org\/10.2147\/IJN.S33015.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4634_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-018-2728-6","volume":"13","author":"P Foroozandeh","year":"2018","unstructured":"Foroozandeh P, Aziz AA. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett. 2018;13(1):1\u201312. https:\/\/doi.org\/10.1186\/s11671-018-2728-6.","journal-title":"Nanoscale Res Lett"},{"issue":"19","key":"4634_CR64","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/jm970190x","volume":"40","author":"A Mazumder","year":"1997","unstructured":"Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H, Eich E, Pommier Y. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem. 1997;40(19):3057\u201363. https:\/\/doi.org\/10.1021\/jm970190x.","journal-title":"J Med Chem"},{"issue":"1","key":"4634_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0923-2516(97)86899-9","volume":"149","author":"S Barthelemy","year":"1998","unstructured":"Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol. 1998;149(1):43\u201352. https:\/\/doi.org\/10.1016\/S0923-2516(97)86899-9.","journal-title":"Res Virol"},{"issue":"49","key":"4634_CR66","doi-asserted-by":"publisher","first-page":"51163","DOI":"10.1074\/jbc.M409024200","volume":"279","author":"K Balasubramanyam","year":"2004","unstructured":"Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK. Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem. 2004;279(49):51163\u201371. https:\/\/doi.org\/10.1074\/jbc.M409024200.","journal-title":"J Biol Chem"},{"issue":"6","key":"4634_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0968-0896(00)82152-5","volume":"1","author":"Z Sui","year":"1993","unstructured":"Sui Z, Salto R, Li J, Craik C, de Montellano PRO. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem. 1993;1(6):415\u201322. https:\/\/doi.org\/10.1016\/S0968-0896(00)82152-5.","journal-title":"Bioorg Med Chem"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04634-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-024-04634-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04634-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:24:46Z","timestamp":1727882686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-024-04634-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4634"],"URL":"https:\/\/doi.org\/10.1186\/s12906-024-04634-8","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"19 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}